KCM
DVAX

Kynam Capital Management’s Dynavax Technologies DVAX Stock Holding History

Kynam Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,375,632
Closed -$21.2M – 42
2025
Q4 		$21.2M Sell
1,375,632
-769,687
-36% -$8.48M 1.35% 20
2025
Q3 		$21.3M Hold
2,145,319
– – 1.59% 16
2025
Q2 		$21.3M Sell
2,145,319
-475,478
-18% -$5.01M 2.29% 14
2025
Q1 		$34M Sell
2,620,797
-3,940,038
-60% -$52.1M 2.86% 13
2024
Q4 		$83.8M Sell
6,560,835
-1,771,852
-21% -$21.4M 4.95% 6
2024
Q3 		$92.8M Buy
8,332,687
+1,250,125
+18% +$13.8M 7.12% 6
2024
Q2 		$79.5M Buy
7,082,562
+2,842,782
+67% +$33.1M 6.14% 6
2024
Q1 		$52.6M Buy
4,239,780
+2,725,397
+180% +$35.5M 5.51% 6
2023
Q4 		$21.2M Buy
1,514,383
+1,014,383
+203% +$14.1M 2.35% 13
2023
Q3 		$7.38M Buy
+500,000
New +$7.03M 1.21% 18

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Kynam Capital Management's DVAX Position: Q1 2026 in Review

Kynam Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 1,375,632 shares — an estimated $21.2M sold.

Kynam Capital Management first reported a position in DVAX in Q3 2023 and held it in 10 quarters. The position peaked at $92.8M in Q3 2024. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Kynam Capital Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Kynam Capital Management sold 1,375,632 Dynavax Technologies shares in Q1 2026, an estimated $21.2M.
  • Kynam Capital Management first reported a position in Dynavax Technologies in Q3 2023 and held it in 10 quarters.
  • Kynam Capital Management's Dynavax Technologies position peaked at $92.8M in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Kynam Capital Management's 13F filing for Q1 2026, filed 15 May 2026.